Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Looks to me like spoofing to manipulate the share price, and it seems someone or a group of people definitely want in on a discount. Staying focused on the end goal, although how these people are allowed to get away with it, God knows.
My understanding is (but not 100%) is that if a company has never listed before, then the process to list can be 6-12 months. However, if already listed on an exchange, this can be as quick as 30 days. Eric never told us when the application was submitted so it could land any second IMO.
Yes US listing rules state that the company only has to have 250,000 shares available for the market which will have been easily achieved today. Anything else they grab is a Brucey bonus. It will be in the MM’s interest to get this stock value up as much as possible before listing to generate interest in a lucrative investment.
I appreciated the dip to add more shares, and am happy to sit tight as know Eric has more up his sleeve :)
Really pleased with the returns on Genflow.
In 2 weeks the investment has double bagged and with US listing imminent, it wouldn’t surprise me if we see further multiples before the listing takes effect.
Especially as Jeff Bezo’s company which relies on Gemflow’s technology is already valued at circa $3bn. Imagine if this company was valued at $3bn, considering it only has 293m shares, a large portion of which, are held by insiders, squeezing the float…
I personally think it will keep going:
- US listing imminent
- Non-dilutive grants in the pipeline
- Golden elixa proven in animals so expect offers for licensing, with human trials imminent
- US patent update due next month
I also personally believe, that if the team can validate that the gene therapy works in humans, this could help reverse the negative effects of MMR and covid vaccinations. Big pharma who now may have concerns for reputational and financial damage would love to get their hands on this science, so would pay limitless funds to get their hands on it, not to even mention the prospect of speeding up therapy for conditions such as liver disease.
Amazing news about the application to be listed in the US.
Especially as there will be no raise or share dilution, allowing the company to reach a much larger audience without watering down the float.
The way it’s been going, it wouldn’t surprise me if the share bagged in 1 session!
Deffo, following on from last years update we saw the share price continue to rise on a daily basis. We’re seeing churn but the entry of new holders is positive as the share price is continuing to hold. I’m confident we’ll see a similar pattern to last year and further rewards. Hoping for £1.15 a share in the near future. Just my personal thoughts, not financial advice, but very pleased nethertheless :)
Fantastic RNS updates! Super pleased from an investors perspective with the work that the team are doing to grow Mitie into a leading Total Facilities Management solution.
With Contracts like these, you just know things are going to get even better:
“In our Q3 update, we highlighted that we were the preferred bidder for two large Strategic Accounts with NATS (TCV of £132 million) and National Grid (TCV of £120 million), and both contracts were awarded in the final quarter. Following a full and extensive re-tender process, Mitie has been retained as strategic partner to the Ministry of Defence for its overseas military base in Cyprus (TCV of up to £643 million), and a further substantial public sector contract is at an advanced stage (TCV of up to £552 million). We also recently signed a new contract with Eurostar (TCV of £40 million) and renewed a contract with a large critical infrastructure organisation (TCV of up to £497 million).”
12k will hopefully bring some lovely returns!
My guess is based on previous RNS’s, it will now be the year end report around the 6th June.
Last year the stock progressively moved over 50% following news, so I have high hopes.
Especially as it’s clear insiders are loading up, even if the RNS’s are being logged end of day and not spiking the market…
With new contracts including Cyprus, National Grid, Durham, Luton, prisons, detention centres and acquisitions of security and solar companies, Mitie is a swan yet to be seen for its beauty by the market.
That gives us time to load up and perhaps have some cheeky day trades in between :)
Been saying for a while, the company no doubt have the skills for reversing gene damage such as via the covid vaccination. Good to see others finally recognising the company for its excellence.
Another one in the bag. Roll on the quarterly and year end report:
https://www.adsadvance.co.uk/dio-awards-mitie-256m-cyprus-facilities-management-contract.html